Alpine Immune Sciences Statistics
Total Valuation
ALPN has a market cap or net worth of $4.22 billion. The enterprise value is $3.90 billion.
| Market Cap | 4.22B |
| Enterprise Value | 3.90B |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALPN has 65.55 million shares outstanding. The number of shares has increased by 49.54% in one year.
| Shares Outstanding | 65.55M |
| Shares Change (YoY) | +49.54% |
| Shares Change (QoQ) | +12.03% |
| Owned by Insiders (%) | 4.65% |
| Owned by Institutions (%) | 91.41% |
| Float | 44.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 71.72 |
| Forward PS | 263.16 |
| PB Ratio | 12.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 66.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.86, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.86 |
| Quick Ratio | 7.80 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -326.36 |
Financial Efficiency
Return on equity (ROE) is -15.50% and return on invested capital (ROIC) is -13.10%.
| Return on Equity (ROE) | -15.50% |
| Return on Assets (ROA) | -11.30% |
| Return on Capital (ROIC) | -13.10% |
| Revenue Per Employee | $414,620 |
| Profits Per Employee | -$226,648 |
| Employee Count | 142 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALPN has paid $103,000 in taxes.
| Income Tax | 103,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +764.83% in the last 52 weeks. The beta is 1.17, so ALPN's price volatility has been higher than the market average.
| Beta (1Y) | 1.17 |
| 52-Week Price Change | +764.83% |
| 50-Day Moving Average | 37.58 |
| 200-Day Moving Average | 20.15 |
| Relative Strength Index (RSI) | 83.57 |
| Average Volume (30 Days) | 2,060,653 |
Short Selling Information
The latest short interest is 5.28 million, so 8.06% of the outstanding shares have been sold short.
| Short Interest | 5.28M |
| Short Previous Month | 5.61M |
| Short % of Shares Out | 8.06% |
| Short % of Float | 11.76% |
| Short Ratio (days to cover) | 4.15 |
Income Statement
In the last 12 months, ALPN had revenue of $58.88 million and -$32.18 million in losses. Loss per share was -$0.64.
| Revenue | 58.88M |
| Gross Profit | 58.88M |
| Operating Income | -44.25M |
| Pretax Income | -32.08M |
| Net Income | -32.18M |
| EBITDA | -31.41M |
| EBIT | -31.98M |
| Loss Per Share | -$0.64 |
Balance Sheet
The company has $327.41 million in cash and $9.91 million in debt, giving a net cash position of $317.50 million or $4.84 per share.
| Cash & Cash Equivalents | 327.41M |
| Total Debt | 9.91M |
| Net Cash | 317.50M |
| Net Cash Per Share | $4.84 |
| Equity / Book Value | 327.94M |
| Book Value Per Share | 5.00 |
| Working Capital | 288.05M |
Cash Flow
In the last 12 months, operating cash flow was -$79.01 million and capital expenditures -$487,000, giving a free cash flow of -$79.50 million.
| Operating Cash Flow | -79.01M |
| Capital Expenditures | -487,000 |
| Free Cash Flow | -79.50M |
| FCF Per Share | -$1.59 |
Margins
Gross margin is 100.00%, with operating and profit margins of -75.16% and -54.66%.
| Gross Margin | 100.00% |
| Operating Margin | -75.16% |
| Pretax Margin | -54.49% |
| Profit Margin | -54.66% |
| EBITDA Margin | -53.34% |
| EBIT Margin | -54.32% |
| FCF Margin | -135.03% |
Dividends & Yields
ALPN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -49.54% |
| Shareholder Yield | -49.54% |
| Earnings Yield | -0.76% |
| FCF Yield | -1.88% |
Analyst Forecast
The average price target for ALPN is $52.29, which is -18.85% lower than the current price. The consensus rating is "Buy".
| Price Target | $52.29 |
| Price Target Difference | -18.85% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 24.19% |
| EPS Growth Forecast (5Y) | 4.89% |
Stock Splits
The last stock split was on July 25, 2017. It was a reverse split with a ratio of 1:4.
| Last Split Date | Jul 25, 2017 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
ALPN has an Altman Z-Score of 48.65 and a Piotroski F-Score of 3.
| Altman Z-Score | 48.65 |
| Piotroski F-Score | 3 |